{"id":6787,"date":"2021-01-18T12:53:02","date_gmt":"2021-01-18T11:53:02","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=6787"},"modified":"2021-10-11T15:57:48","modified_gmt":"2021-10-11T14:57:48","slug":"control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/","title":{"rendered":"Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI"},"content":{"rendered":"\n<p><a rel=\"noreferrer noopener\" href=\"https:\/\/eu-jamrai.eu\/\" target=\"_blank\">EU-JAMRAI<\/a> is a European Union Joint Action on Antimicrobial Resistance (AMR) and Healtcare-associated Infections (HCAI) that brings together 44 partners and more than 40 stakeholders. Its mission is to foster synergies among EU member states by developing and implementing effective One Health policies to fight the rising threat of AMR and to reduce HCAI. <\/p>\n\n\n\n<p>EU-JAMRAI is co-funded by its partners and the European Union&#8217;s health program (2014-2020 &#8211; GA n\u00ba761296).<\/p>\n\n\n\n<p>EU-JAMRAI is promoting good pratices for a better use of antibiotics in Europe, and produced 6 policy briefs related to that topic.<\/p>\n\n\n\n<p>More about the 6 policy briefs <a href=\"https:\/\/eu-jamrai.eu\/promoting-good-practices-policy-briefs-recommendations\/\" target=\"_blank\" rel=\"noreferrer noopener\">on the dedicated JAMRAI page<\/a>:<\/p>\n\n\n\n<ul><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/01\/201020_EUJAMRAI_policy-brief_WP7_appropriate-use-of-antibiotics-one-health-perspective.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Appropriate use of antibiotics in a One Health perspective<\/a><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/01\/201022_EUJAMRAI_policy-brief_WP4_core-elements.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">The need to develop core elements at the European level on antimicrobial stewardship (AMS) and infection prevention and control (IPC)<\/a><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/01\/201022_EUJAMRAI_policy-brief_WP4_indicators.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">The need to develop indicators and targets for AMR action plans in the EU<\/a><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/01\/201116_EUJAMRAI_policy-brief_WP4_OHN.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">The need for a reinforced AMR One Health Network<\/a><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/01\/201207_EUJAMRAI_policy-brief_WP9_research-on-IPC.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">The urgent need to foster research on infection prevention and control to improve health security<\/a><\/li><li><a href=\"https:\/\/eu-jamrai.eu\/wp-content\/uploads\/2021\/01\/EUjamrai_policy-brief-hub-incentives_2020.12.11.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Incentivizing antibiotic access and innovation<\/a><\/li><\/ul>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>EU-JAMRAI is a European Union Joint Action on Antimicrobial Resistance (AMR) and Healtcare-associated Infections (HCAI) that brings together 44 partners and more than 40 stakeholders. Its mission is to foster synergies among EU member states by developing and implementing effective One Health policies to fight the rising threat of AMR and to reduce HCAI. EU-JAMRAI [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":6793,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,37],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-18T11:53:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-11T14:57:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/JAMRAI-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"429\" \/>\n\t<meta property=\"og:image:height\" content=\"104\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI\",\"datePublished\":\"2021-01-18T11:53:02+00:00\",\"dateModified\":\"2021-10-11T14:57:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/\"},\"wordCount\":186,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/JAMRAI-logo.jpg\",\"articleSection\":[\"Actualit\u00e9s\",\"Bilans, rapports et recommandations\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/\",\"name\":\"Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/JAMRAI-logo.jpg\",\"datePublished\":\"2021-01-18T11:53:02+00:00\",\"dateModified\":\"2021-10-11T14:57:48+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/JAMRAI-logo.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/JAMRAI-logo.jpg\",\"width\":429,\"height\":104,\"caption\":\"Cr\u00e9dit : EU-JAMRAI\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/","og_locale":"en_GB","og_type":"article","og_title":"Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2021-01-18T11:53:02+00:00","article_modified_time":"2021-10-11T14:57:48+00:00","og_image":[{"width":429,"height":104,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/JAMRAI-logo.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI","datePublished":"2021-01-18T11:53:02+00:00","dateModified":"2021-10-11T14:57:48+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/"},"wordCount":186,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/JAMRAI-logo.jpg","articleSection":["Actualit\u00e9s","Bilans, rapports et recommandations"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/","name":"Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/JAMRAI-logo.jpg","datePublished":"2021-01-18T11:53:02+00:00","dateModified":"2021-10-11T14:57:48+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/JAMRAI-logo.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/01\/JAMRAI-logo.jpg","width":429,"height":104,"caption":"Cr\u00e9dit : EU-JAMRAI"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/control-of-amr-at-the-european-level-6-policy-briefs-and-recommendations-issued-by-the-jamrai\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"Control of AMR at the European level: 6 policy briefs and recommendations issued by the JAMRAI"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-05-04 23:56:44","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/6787"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=6787"}],"version-history":[{"count":24,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/6787\/revisions"}],"predecessor-version":[{"id":17997,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/6787\/revisions\/17997"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/6793"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=6787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=6787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=6787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}